GE HealthCare Technologies Inc. Common Stock (GEHC)

Price$74.15

Favorite Metrics

Price vs S&P 500 (26W)-3.61%

Price vs S&P 500 (4W)-2.30%

Market Capitalization$34.07B

P/E Ratio (Annual)16.35x

Indicated Dividend Yield (Annual)0.19%

All Metrics

P/CF (Annual)17.14x

Book Value / Share (Quarterly)$22.77

P/TBV (Annual)4.04x

Indicated Dividend (Annual)$0.14

Revenue Growth (3Y)3.99%

Cash Flow / Share (Quarterly)$3.30

Payout Ratio (TTM)3.07%

Price vs S&P 500 (YTD)-13.11%

Gross Margin (TTM)39.98%

Net Profit Margin (TTM)10.11%

EPS (TTM)$4.55

10-Day Avg Trading Volume3.02M

EPS Excl Extra (TTM)$4.55

Revenue Growth (5Y)3.74%

EPS (Annual)$4.55

Dividend / Share (Annual)$0.14

ROI (Annual)10.20%

Gross Margin (Annual)39.99%

Net Profit Margin (5Y Avg)10.30%

Cash / Share (Quarterly)$9.86

P/E Basic Excl Extra (TTM)16.34x

Revenue Growth QoQ (YoY)7.13%

EPS Growth (5Y)-31.63%

P/E Normalized (Annual)16.35x

ROA (Last FY)5.65%

Revenue Growth TTM (YoY)4.85%

EBITD / Share (TTM)$7.32

ROE (5Y Avg)19.93%

Operating Margin (TTM)13.40%

Cash Flow / Share (Annual)$3.30

P/B Ratio3.28x

P/B Ratio (Quarterly)3.60x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)1.92x

Net Interest Coverage (TTM)10.26x

ROA (TTM)5.87%

EPS Growth QoQ (YoY)-18.13%

EV / EBITDA (TTM)11.82x

EPS Incl Extra (Annual)$4.55

Current Ratio (Annual)1.37x

Quick Ratio (Quarterly)1.10x

3-Month Avg Trading Volume3.39M

52-Week Price Return21.44%

EV / Free Cash Flow (Annual)26.33x

P/E Incl Extra (TTM)16.34x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$20.29

P/S Ratio (Annual)1.65x

Asset Turnover (Annual)0.56x

52-Week High$89.77

Operating Margin (5Y Avg)13.77%

EPS Excl Extra (Annual)$4.55

CapEx CAGR (5Y)13.23%

26-Week Price Return5.14%

Quick Ratio (Annual)1.10x

13-Week Price Return-12.47%

Total Debt / Equity (Annual)0.97x

Current Ratio (Quarterly)1.37x

Enterprise Value$39,619.62

Revenue / Share Growth (5Y)3.59%

Asset Turnover (TTM)0.58x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)5.93x

Pretax Margin (Annual)13.42%

Cash / Share (Annual)$9.86

3-Month Return Std Dev32.65%

Gross Margin (5Y Avg)40.43%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)1.89%

ROE (Last FY)20.08%

Net Interest Coverage (Annual)10.32x

EPS Basic Excl Extra (Annual)$4.55

P/FCF (TTM)22.64x

Receivables Turnover (TTM)4.31x

EV / Free Cash Flow (TTM)26.33x

Total Debt / Equity (Quarterly)0.97x

EPS Incl Extra (TTM)$4.55

Receivables Turnover (Annual)4.31x

ROI (TTM)10.59%

P/S Ratio (TTM)1.65x

Pretax Margin (5Y Avg)13.73%

Revenue / Share (Annual)$45.03

Tangible BV / Share (Annual)$20.29

Forward P/E14.65x

Free OCF CAGR (5Y)-8.60%

Price vs S&P 500 (52W)-13.66%

P/E Ratio (TTM)16.34x

EPS Growth TTM (YoY)4.78%

Year-to-Date Return-8.97%

5-Day Price Return1.12%

EPS Normalized (Annual)$4.55

ROA (5Y Avg)6.40%

Net Profit Margin (Annual)10.10%

Month-to-Date Return4.89%

Cash Flow / Share (TTM)$4.85

EBITD / Share (Annual)$7.32

EPS Growth (3Y)2.53%

Operating Margin (Annual)13.40%

LT Debt / Equity (Annual)0.91x

P/CF (TTM)17.14x

ROI (5Y Avg)11.09%

P/E Excl Extra (TTM)16.34x

LT Debt / Equity (Quarterly)0.91x

EPS Basic Excl Extra (TTM)$4.55

P/TBV (Quarterly)4.04x

Payout Ratio (Annual)3.07%

P/B Ratio (Annual)3.60x

Dividend / Share (TTM)$0.14

Inventory Turnover (TTM)5.93x

Pretax Margin (TTM)13.43%

Book Value / Share (Annual)$22.77

Price vs S&P 500 (13W)-15.34%

Net Margin Growth (5Y)-34.00%

Dividend Yield (TTM)0.19%

Beta1.23x

P/FCF (Annual)22.64x

Revenue / Share (TTM)$45.03

ROE (TTM)21.24%

52-Week Low$59.95

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

3.96

3.93

Industry Peers — X-Ray Equipment(3)

Symbol	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
GEHCGE HealthCare Technologies Inc. Common Stock	1.65x	3.74%	39.98%	13.40%	$74.15
PHGKONINKLIJKE PHILIPS N.V.	1.78x	0.59%	45.43%	8.08%	$29.19
HOLXHologic Inc	4.11x	1.66%	56.51%	17.56%	$76.01
BFLYButterfly Network, Inc.	14.22x	—	46.85%	-88.53%	$5.49

About

GE HealthCare Technologies is a global leader in medical imaging and diagnostic equipment, with commanding market share in imaging and ultrasound. The company operates across four segments—imaging (45% of revenue), advanced visualization (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%)—with balanced geographic exposure across the U.S. (46%), Europe/Middle East/Africa (26%), China (11%), and emerging markets. Approximately half of its revenue is recurring, including service contracts, pharmaceutical diagnostics, and digital healthcare solutions, providing stable cash flow alongside its hardware business.